Obetrol Combination of Dextroamphetamine Psychostimulant Amphetamine Psychostimulant Methamphetamine Psychostimulant Clinical data Pregnancy cat. C(US) Legal status Schedule II (US) Dependence liability High Routes Oral Identifiers ATC code ? (what is this?)
Obetrol is a pharmaceutical stimulant, amphetamine, used as an anorexiant to treat exogenous obesity with racemic amphetamine and methamphetamine salts. Obetrol was a stimulant based diet pill popular in the 1950s and 1960s.
There is a misconception among some that the ingredients in the drug Obetrol have always been the same as those in the present day drug Adderall. In fact, the drug Obetrol was reformulated at least once.
A look at the history of the drug and its manufacturer(s) may help to clarify this. In the 1950s, Obetrol was manufactured by Obetrol Pharmaceuticals, in Brooklyn, New York. The Company later became a Division of Rexar Pharmacal Corporation, which was also headquartered in Brooklyn. Sometime prior to 1972, Rexar Pharmacal moved its manufacturing facilities, including its Obetrol Pharmaceutical Division, to Valley Stream, New York. By the 1990s, Obetrol Pharmaceuticals had been wholly absorbed by Rexar Pharmacal, and was no longer noted as a "division" of Rexar.
Per the 1972 Physicians' Desk Reference, Obetrol contained (per 10 mg tablet):
- 2.5 mg methamphetamine saccharate
- 2.5 mg methamphetamine hydrochloride
- 2.5 mg racemic amphetamine sulfate
- 2.5 mg dextroamphetamine sulfate
Obetrol was also available in 20 mg. tablets which contained twice the quantity of its ingredients, in the same proportions. The 10 mg. tablets were blue, and the 20 mg. were orange. Both were inscribed with the letters, "OP."
By the 1980s, the use of amphetamines—particularly methamphetamine—as an adjunct to diet and exercise in the treatment of exogenous obesity had become frowned upon by many in the medical community. As the decades evolved, so did the composition of Obetrol. By 1995, the year Shire Pharmaceuticals (then known as Shire-Richwood) acquired Rexar Pharmacal, Obetrol 10 mg. and 20 mg. tablets contained, (in equal proportions):
These tablets were also blue and orange, but were inscribed with the letters, "OB."
When Shire acquired Rexar, the name of the drug was changed from Obetrol to Adderall, and the drug was marketed for use in the treatment of Attention Deficit Disorder (in both children and adults). Rexar continued to manufacture the drug for several years. During these years the drug Adderall was indeed identical to the most recent formulation of Obetrol, except that the inscription on the pills was changed to "AD."
Sometime after 2000, Shire closed the Rexar manufacturing facility. The manufacture of "brand name" Adderall was outsourced to a vendor in North Carolina. In fact, no Shire manufacturing facility (other than the Rexar facility it had acquired) produced immediate-release Adderall at any time. Other companies had begun manufacturing generic versions of Adderall, and the trade name was eventually sold to Barr Pharmaceuticals (acquired by Teva in 2008).
In conclusion, while it is accurate to state that Adderall was identical in composition to Obetrol when first marketed in the mid-1990s, it is worth noting that the changes made to the formulation of Obetrol since it was introduced are of significance. There is no drug commercially marketed called Obetrol at this time, nor has there been since Shire acquired Rexar Pharmacal.
- ^ Rasmussen, Nicolas (2008-03-01). "On Speed: The Many Lives of Amphetamine". New York University Press. pp. 148 Fig. 33. http://hist-phil.arts.unsw.edu.au/staff/staff.php?first=Nicolas&last=Rasmussen. Retrieved 2009-01-27.
Wikimedia Foundation. 2010.